Expert Opinion on Drug Safety
Volume 22, 2023 - Issue 3
Original Research
Analysis and visualization of the course and burden over time of adverse drug reactions (ADRs) attributed to TNFα-inhibitors in patients with inflammatory rheumatic diseases (IRDs)
Merel de Boera Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, the NetherlandsCorrespondence[email protected]
https://orcid.org/0000-0001-5433-1313View further author information
https://orcid.org/0000-0001-5433-1313View further author information, , , Martijn B.A van Doornb Department of Dermatology, Erasmus MC, Rotterdam, the Netherlands;c Centre for Human Drug Research, Leiden, the Netherlandshttps://orcid.org/0000-0003-1672-7899View further author information
https://orcid.org/0000-0003-1672-7899View further author information, , Michael T Nurmohamedf Amsterdam Rheumatology Immunology Center | Reade, Amsterdam, the Netherlandshttps://orcid.org/0000-0002-6274-1934View further author information
https://orcid.org/0000-0002-6274-1934View further author information, , , Harald E Vonkemani Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, the Netherlands;j Department of Psychology, Health and Technology, University of Twente, Enschede, the Netherlandshttps://orcid.org/0000-0003-3792-7718View further author information
https://orcid.org/0000-0003-3792-7718View further author information & Naomi T Jessuruna Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, the Netherlandshttps://orcid.org/0000-0002-8267-1259View further author information
https://orcid.org/0000-0002-8267-1259View further author information show all